2009
DOI: 10.4076/1757-1626-2-8863
|View full text |Cite
|
Sign up to set email alerts
|

Giant adrenal myelolipoma, a rare urological issue with increasing incidence: a case report

Abstract: IntroductionAdrenal myelolipomas are relatively rare, non-functioning benign tumours composed of mature fatty and active hematopoietic elements. They can be asymptomatic, even if their size is massive. Diagnosis is relatively simple using ultrasound, computed tomography and magnetic resonance imaging. Surgical resection through an extraperitoneal approach is advocated in cases of symptomatic or large myelolipomas exceeding 5-cm in diameter. Their low incidence seems to be increasing from 0.2% to 10% during the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
28
0
2

Year Published

2010
2010
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(30 citation statements)
references
References 9 publications
0
28
0
2
Order By: Relevance
“…Associations noted with adrenal myelolipomata such as obesity, hypertension and diabetes were present in this patient [6]. They have a relatively slow growth rate with a doubling time of 4.6 to 95.1 months [5].…”
Section: Discussionmentioning
confidence: 54%
“…Associations noted with adrenal myelolipomata such as obesity, hypertension and diabetes were present in this patient [6]. They have a relatively slow growth rate with a doubling time of 4.6 to 95.1 months [5].…”
Section: Discussionmentioning
confidence: 54%
“…The most widely accepted amongst all of them is that due to metaplastic change in the reticuloendothelial cells of blood capillaries in response to stimuli including necrosis, infection or stress [8]. Prolonged stimulation with high level of adrenocoticotropic hormone or adrenal androgen also has been sought as cause of this benign lesion.…”
Section: Discussionmentioning
confidence: 99%
“…Gagner et al, introduced laparoscopic adrenalectomy for the treatment of both functioning and non-functioning adrenal tumours [15]. Usually lesions which are asymptomatic and measure <5cm are monitored over a period of 1 to 2 years with imaging [8].…”
Section: Discussionmentioning
confidence: 99%
“…The treatment of adrenal myelolipomas should be individualized [9]. The patient has a small, less than 5 cm in diameter, and asymptomatic myelolipoma, that could be observed conservatively around 6 -12 months interval follow-up by using ultrasound or CT for a 1 -2 year period [2,9].…”
Section: Discussionmentioning
confidence: 99%
“…The patient has a small, less than 5 cm in diameter, and asymptomatic myelolipoma, that could be observed conservatively around 6 -12 months interval follow-up by using ultrasound or CT for a 1 -2 year period [2,9]. On the contrary, a symptomatic lesion or a large than 5 cm in diameter myelolipoma should be surgically excised, because there are reports about spontaneous rupture and hemorrhage risks of the mass leading to life-threatening cardiovascular shock [9]. The classical treatment of both functioning and non-functioning adrenal tumors has become laparoscopic adrenalectomy by starting to do minimally invasive surgery [2].…”
Section: Discussionmentioning
confidence: 99%